Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM) — Stella

Home/Type 1 Diabetes/Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

View on ClinicalTrials.gov

Recruiting

Back to Type 1 Diabetes trials

Liom Non-invasive Continuous Glucose Monitor "Clinical Demo" (niCGM)

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Profil for Stoffwechselforschung GmbH, Neuss, Nordrhein-Westfallen

Key details

Sponsor

Liom Health AG

Collaborators

Profil Institut für Stoffwechselforschung GmbH

Enrollment target

~80 participants

Started

February 2024

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.